白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600332 白云山

已收盘 04-30 15:00:00

{"stockData":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":32.08,"timestamp":1714460400000,"preClose":31.82,"halted":0,"volume":11340625,"delay":0,"floatShares":1406000000,"shares":1626000000,"eps":2.5251,"marketStatus":"已收盘","marketStatusCode":5,"change":0.26,"latestTime":"04-30 15:00:00","open":31.85,"high":32.4,"low":31.71,"amount":364000000,"amplitude":0.0217,"askPrice":32.08,"askSize":319,"bidPrice":32.07,"bidSize":130,"shortable":0,"etf":0,"ttmEps":2.5251,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":31.82,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":35,"lowLimit":28.64,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1625790949,"pbRate":1.41,"roa":"--","roe":"5.45%","epsLYR":2.495,"committee":-0.209629,"marketValue":52155000000,"floatMarketCap":45101000000,"peRate":12.704447,"changeRate":0.0082,"turnoverRate":0.0081,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-06。"},"requestUrl":"/m/hq/s/600332/wiki","defaultTab":"wiki","newsList":[{"id":"2432699611","title":"白云山获信达证券买入评级，24Q1业绩稳健增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2432699611","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432699611?lang=zh_cn&edition=full","pubTime":"2024-05-02 10:12","pubTimestamp":1714615923,"startTime":"0","endTime":"0","summary":"5月2日，白云山获信达证券买入评级，近一个月白云山获得1份研报关注。研报预计白云山2024-2026年营收分别为824.52/879.97/941.33亿元，归母净利润分别为43.75/50.25/56.53亿元。研报认为，白云山公司将持续深耕市场、培育动能，推动各业务板块高质量发展。推进大南药研发创新，丰富大健康产品矩阵。以数字化夯实“医疗+商业+电商+零售”四位一体全渠道战略，积极推动数字经济与医药健康产业的融合发展。风险提示：行业政策变化风险，市场风险，产品质量控制风险，药物研发风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050210120787c9628f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050210120787c9628f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431384521","title":"白云山：旗下王老吉与肯德基合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2431384521","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2431384521?lang=zh_cn&edition=full","pubTime":"2024-04-30 10:39","pubTimestamp":1714444777,"startTime":"0","endTime":"0","summary":"4月29日，白云山(600332)旗下子公司王老吉宣布与肯德基合作，联合推出“王老吉风味气泡美式”，在肯德基全国一万家门店上线，售卖将持续到5月底。王老吉副总经理叶继曾表示，此次与肯德基的联名是一次全面而深入的合作，涵盖了从联名新品到线下主题店的打造，再到线上联合传播的全方位、立体化的联动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301045548b645da5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301045548b645da5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431822325","title":"【企业动态】白云山新增1件法院诉讼，案由为劳动争议","url":"https://stock-news.laohu8.com/highlight/detail?id=2431822325","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431822325?lang=zh_cn&edition=full","pubTime":"2024-04-30 05:51","pubTimestamp":1714427500,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，4月28日白云山（600332）新增1件法院诉讼如下：案号：（2024）粤01民终15120号法院：广东省广州市中级人民法院案由：劳动争议原告：童某某被告：广州白云山医药集团股份有限公司案件类型：民事立案日期：2024年4月28日数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000012143.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430277689","title":"岭南控股最新公告：子公司拟615.18万元收购白云山旅发100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2430277689","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430277689?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:31","pubTimestamp":1714138285,"startTime":"0","endTime":"0","summary":"岭南控股公告，控股子公司广州广之旅国际旅行社股份有限公司的全资子公司广州广之旅悦景目的地旅游发展有限公司拟以自有资金人民币615.18万元向广州市旅业有限公司购买广州市白云山旅游发展有限公司100%的股权。本次交易完成后，广之旅悦景公司将持有白云山旅发100%股权，白云山旅发成为广之旅悦景公司的全资子公司。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600054379.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430225954","title":"图解白云山一季报：第一季度单季净利润同比增2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430225954","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430225954?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:46","pubTimestamp":1714124784,"startTime":"0","endTime":"0","summary":"证券之星消息，白云山2024年一季报显示，公司主营收入229.46亿元，同比上升6.09%；归母净利润19.58亿元，同比上升2.59%；扣非净利润18.34亿元，同比上升0.33%；负债率50.81%，投资收益1.02亿元，财务费用-1990.97万元，毛利率22.13%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600042033.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430223004","title":"白云山(600332.SH)发布一季度业绩，净利润19.58亿元，同比增长2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430223004","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430223004?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:42","pubTimestamp":1714124573,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(600332.SH)发布2024年第一季度报告，公司营业收入229.46亿元，同比增长6.09%;归属于上市公司股东的净利润19.58亿元，同比增长2.59%;归属于上市公司股东的扣除非经常性损益的净利润18.34亿元，同比增长0.33%;基本每股收益1.204元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111740.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430803223","title":"白云山(00874)第一季度归母净利润19.58亿元 同比增加2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430803223","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430803223?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:30","pubTimestamp":1714123805,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布2024年第一季度业绩，该集团期内取得营业收入229.46亿元(人民币，下同)，同比增加6.09%;归属于上市公司股东的净利润19.58亿元，同比增加2.59%;基本每股收益1.204元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111693.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430228614","title":"白云山(00874)：明兴药业的盐酸多巴胺注射液获得药品补充申请批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2430228614","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430228614?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:24","pubTimestamp":1714123461,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)公布，近日，公司全资子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到国家药品监督管理局签发的《药品补充申请批准通知书》，盐酸多巴胺注射液已按质量与疗效一致性评价申报途径进行补充申请，从而获得国家药监局批准变更相关内容。公告称，本次明兴药业的盐酸多巴胺注射液获得药品补充申请批件，有利于提升该药品的市场竞争力。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111678.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430240725","title":"白云山(00874)拟续聘大信会计师事务所","url":"https://stock-news.laohu8.com/highlight/detail?id=2430240725","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430240725?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:17","pubTimestamp":1714123079,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(00874)发布公告，该公司拟续聘大信会计师事务所(特殊普通合伙)为会计师事务所。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111655.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430228038","title":"白云山2024年一季度净利润19.58亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430228038","media":"同花顺资讯","top":-1,"share":"https://www.laohu8.com/m/news/2430228038?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:04","pubTimestamp":1714122275,"startTime":"0","endTime":"0","summary":"4月27日，A股上市公司白云山发布2024年一季度业绩报告。其中，净利润19.58亿元，同比增长2.59%。净利润19.58亿元，同比增长2.59%从营收和利润方面看，公司本报告期实现营业总收入229.46亿元，同比增长6.09%，净利润19.58亿元，同比增长2.59%，基本每股收益为1.20元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261704177923d0d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261704177923d0d9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430243226","title":"V观财报｜白云山一季度净利同比增2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430243226","media":"中新经纬","top":-1,"share":"https://www.laohu8.com/m/news/2430243226?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:59","pubTimestamp":1714121963,"startTime":"0","endTime":"0","summary":"白云山26日盘后披露财报显示，2024年第一季度公司实现营收229.46亿元，同比增长6.09%；归属于上市公司股东的净利润19.58亿元，同比增长2.59%。（中新经纬APP）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261755127923d815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261755127923d815&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430247199","title":"白云山最新公告：一季度净利润同比增长2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430247199","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430247199?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:51","pubTimestamp":1714121466,"startTime":"0","endTime":"0","summary":"白云山发布2024年第一季度报告，第一季度归母净利润19.58亿元，同比增长2.59%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600037400.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430772242","title":"白云山：第一季度归母净利润19.58亿元，同比增长2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430772242","media":"国际金融报","top":-1,"share":"https://www.laohu8.com/m/news/2430772242?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:49","pubTimestamp":1714121379,"startTime":"0","endTime":"0","summary":"白云山发布2024年第一季度报告，第一季度归母净利润19.58亿元，同比增长2.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261649477923ce1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261649477923ce1d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430526005","title":"北向资金4月25日净买入白云山0.90万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430526005","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430526005?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:30","pubTimestamp":1714095011,"startTime":"0","endTime":"0","summary":"4月25日, 北向资金增持白云山0.90万股，连续5日增持。截止当日收盘，沪股通共持有白云山3445.91万股，占流通股2.45%。沪股通增持金额前五个股分别为招商银行、中国平安、紫金矿业、中控技术、中信证券。白云山近5个交易日上涨1.79%，沪股通累计增持255.92万股；近20个交易日上涨9.50%，沪股通累计增持429.99万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260931078b54f14a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260931078b54f14a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429448854","title":"白云山04月24日主力资金流出439万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2429448854","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429448854?lang=zh_cn&edition=full","pubTime":"2024-04-24 15:17","pubTimestamp":1713943065,"startTime":"0","endTime":"0","summary":"04月24日, 白云山股价跌0.13%，报收31.32元，成交金额2.36亿元，换手率0.54%，振幅1.59%，量比0.55。白云山今日主力资金净流出439万元，连续3日净流出，上一交易日主力净流出3763万元，今日环比减少88.33%。该股近5个交易日上涨3.26%，主力资金累计净流出9512万元；近20日主力资金累计净流出1.64亿元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404241520168b4dcdef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404241520168b4dcdef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429017475","title":"【广药白云山】新《公司法》亮点解读","url":"https://stock-news.laohu8.com/highlight/detail?id=2429017475","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2429017475?lang=zh_cn&edition=full","pubTime":"2024-04-24 10:43","pubTimestamp":1713926580,"startTime":"0","endTime":"0","summary":"【广药白云山】新《公司法》亮点解读校对：赵燕","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042410434887a8a62c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042410434887a8a62c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429127869","title":"白云山获融资买入0.21亿元，近三日累计买入0.87亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429127869","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429127869?lang=zh_cn&edition=full","pubTime":"2024-04-24 08:24","pubTimestamp":1713918265,"startTime":"0","endTime":"0","summary":"4月23日，沪深两融数据显示，白云山获融资买入额0.21亿元，居两市第315位，当日融资偿还额0.20亿元，净买入98.20万元。最近三个交易日，19日-23日，白云山分别获融资买入0.41亿元、0.24亿元、0.21亿元。融券方面，当日融券卖出0.22万股，净买入1.72万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240824458b4c7d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240824458b4c7d1a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429948760","title":"白云山最新公告：头孢克肟片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2429948760","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429948760?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:30","pubTimestamp":1713778212,"startTime":"0","endTime":"0","summary":"白云山公告，公司分公司白云山制药总厂收到国家药监局签发的药品补充申请批件通知书，头孢克肟片通过仿制药质量和疗效一致性评价。头孢克肟为第三代头孢菌素类抗生素，适用于对头孢克肟敏感的链球菌属(肠球菌除外)，肺炎球菌、淋球菌等引起的部分细菌感染性疾病。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200020621.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429091005","title":"白云山(00874.HK)分公司药物通过国家药监局仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2429091005","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429091005?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:13","pubTimestamp":1713777180,"startTime":"0","endTime":"0","summary":"白云山(00874.HK) (600332.SH) 公布，分公司白云山制药总厂，接获国家药品监督管理局签发的《药品补充申请批件通知书》指，Cefixime已通过仿制药质量及疗效一致性评价。相关药物为第三代头孢菌素类抗生素，并适用于对Cefixime敏感的链球菌属(肠球菌除外)、肺炎球菌、淋球菌等引起的细菌感染性疾病。公司披露，白云山制药总厂针对该药品一致性评价，已投入的未审计研发费用约1,664.04万元人民币。(js/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-22 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20200312162542031_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20200312162542031_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1344009/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2001-02-06","address":"广东省广州市荔湾区沙面北街45号","stockEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.112},{"period":"3month","weight":0.1738},{"period":"6month","weight":0.0853},{"period":"1year","weight":-0.0198},{"period":"ytd","weight":0.1217}],"companyName":"广州白云山医药集团股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"162579万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":"　　广州白云山医药集团股份有限公司主营业务中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研究开发、制造与销售;西药、中药和医疗器械的批发、零售和进出口业务;大健康产品的研发、生产与销售;医疗服务、健康管理、养生养老等健康产业投资。公司产品主要包括中成药、中药饮片、化学制剂、化学原料药、医药流通。集团是全国最大的制药企业集团之一。本集团及合营企业拥有国家级研发机构7家，国家级企业技术中心1家，博士后工作站2家。","serverTime":1714923050788,"listedPrice":9.8,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(600332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,600332,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(600332)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(600332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}